Where evening primrose oil is permitted, and what the file must show
Evening primrose oil has a long history as a food supplement ingredient in the EU, the US and the UK, and the powder is that oil dispersed in a modified-starch matrix. What a market file has to prove is narrower than the oil's history: the route, the carrier, the contaminant results and the label. Those four items are checked separately, and a failure in any one is enough to stop a launch.
The oil has a history of use; the carrier, the contaminants and the label are what each market file still has to prove.
Four checks, not one
Four questions decide an ingredient file, and they are separate: is the ingredient permitted, is the food category allowed, do the contaminants meet the limits, and does the label carry the right words? A lot can pass the metals panel and still sit on the wrong route; a correct route does not fix a label that omits the carrier. The powder adds a carrier, a processing step and a particle-size specification. The carrier and the process must be permitted, and the carrier must be declared.
The European Union and the United Kingdom
Directive 2002/46/EC sets the EU food-supplement framework. It harmonises the vitamin and mineral lists only; an oil such as evening primrose is left to national rules, so the member state matters. Evening primrose oil was in food-supplement use before 15 May 1997 and is not a novel food on that basis; check the current novel-food catalogue entry for the oil and the process, because a new extraction or concentration step can change the answer.
The general food law Regulation (EC) No 178/2002 sets the safety duty. Labelling follows Regulation (EU) No 1169/2011, including the ingredient list and the allergen declaration. Contaminants follow Regulation (EU) 2023/915, and claims follow Regulation (EC) No 1924/2006. The carrier belongs on the label: modified starch has its own name and, where applicable, an E number, and any antioxidant is declared in the same list.
The UK applies the retained framework: the GB novel-foods register is the route reference for Great Britain, Northern Ireland follows the EU regime, and the labelling, contaminant and claims rules mirror the EU structure. Check the current GB text for the specific oil and carrier.
The United States
US law covers evening primrose oil as a dietary ingredient under DSHEA. There is no pre-market approval of a supplement or its label; the firm carries the responsibility. Manufacturing follows the supplement GMPs in 21 CFR 111, and labelling follows 21 CFR 101. An ingredient first marketed after 15 October 1994 is a new dietary ingredient and needs a 75-day pre-market notification, unless its history of use removes it from that category; evening primrose oil has a long US supplement history, and the supplier should state the basis for its position.
FALCPA's major-allergen list — milk, egg, fish, crustacean shellfish, tree nuts, wheat, peanuts, soybeans and sesame — does not include evening primrose. The oil is still a botanical ingredient and the carrier is a food ingredient, so the finished label has to name both. A separate California regime, Proposition 65, is a warning law rather than a specification limit; a lead result near the specification ceiling is a reason to check it.
Contaminants and the specification
| Parameter | Catalog limit | EU supplement limit | Note |
|---|---|---|---|
| Lead | ≤3 mg/kg | 3.0 mg/kg | Regulation (EU) 2023/915 |
| Cadmium | ≤1 mg/kg | 1.0 mg/kg | Regulation (EU) 2023/915 |
| Mercury | ≤0.1 mg/kg | 0.10 mg/kg | Regulation (EU) 2023/915 |
| Arsenic | ≤2 mg/kg | No harmonised EU maximum | National or customer limits apply |
| Peroxide value | ≤8.0 meq/kg | Not a regulatory maximum | Oxidation specification |
| p-Anisidine value | ≤20.0 | Not a regulatory maximum | Oxidation specification |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Set by the specification | Confirm the customer's criteria |
The EU ceilings apply to the supplement as sold. The powder's contribution is the limit multiplied by its use level; the rest of the formula contributes as well, so run the calculation on the finished product. Peroxide and p-anisidine values are lipid-quality parameters, not contaminants. They belong on the certificate and in the stability file, but they have no EU maximum; a customer can still set a tighter one.
The claim boundary
EU and UK health claims sit under Regulation 1924/2006 and the GB register. A claim has to be authorised; a footnote cannot rescue wording that is not on the register. At the time of this review, neither evening primrose oil nor GLA has an authorised health claim. GLA has no NRV and no specific nutrition claim in the Regulation's Annex, so a “source of GLA” claim needs a legal check.
A US supplement may carry a structure/function statement if the disclaimer is attached. A disease claim needs an authorised qualified health claim; without one, the product is a drug. The line is drawn by the words on the pack. In all three markets, the defensible position is to describe the material, its manufacture and its testing, and to leave disease, disease-related use and prevention out of the copy.
The file a buyer should hold
| Document | What it proves | Common gap |
|---|---|---|
| Specification | Source, oil load, GLA basis, limits and methods | GLA without a basis |
| Batch COA | What the lot measured against the release limits | A result column that repeats the specification |
| Allergen and source statement | The botanical source and the allergen status | A generic statement with no lot |
| Carrier declaration | The modified starch and any antioxidant | Carrier named only as “starch” |
| Route note (EU) | The history-of-use or novel-food position | A generic “EU compliant” line |
| US ingredient note | The dietary-ingredient basis and any NDI position | No history-of-use evidence |
| SDS and stability data | Handling, storage and shelf life | A shelf life without data |
| Contaminant and micro data | The lot meets the agreed limits | Numbers without methods or LOQs |
The compliance checklist
- Name the botanical source and the oil load; confirm the GLA basis.
- Name the carrier and any antioxidant, and check their status in the destination market.
- Confirm the route: EU history of use or novel-food position; US dietary-ingredient basis; UK retained rules.
- Compare lead, cadmium, mercury, arsenic and microbiology with the limits for the finished product.
- Check the allergen statement against the source and the carrier.
- Check the label: ingredient names, carrier, antioxidant, net quantity and storage condition.
- Keep claims to the authorised list and out of disease language.
- Keep the specification, COA, SDS, stability file and route notes together, dated.
The catalog limits are on the evening primrose oil powder product page. The certificate lines are on the COA page, the source and label choices are on the grades page, and the source evidence is on the identity page. The market routes are set out on the EU, US and UK regulatory pages; the allergen list is explained in the Annex II glossary entry.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation